1h Free Analyst Time
The acute ischemic stroke therapeutics market is poised to grow by $1524.49 mn during 2023-2027, accelerating at a CAGR of 5.72% during the forecast period. The report on the acute ischemic stroke therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of disease, increasing adoption of NOACs, and increasing prevalence of sedentary lifestyles.
The acute ischemic stroke therapeutics market is segmented as below:
By Type
- Thrombolytics
- Anticoagulants
- Antiplatelets
- Antihypertensives
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the acute ischemic stroke therapeutics market covers the following areas:
- Acute ischemic stroke therapeutics market sizing
- Acute ischemic stroke therapeutics market forecast
- Acute ischemic stroke therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Market Segmentation by Distribution Channel
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Vendor Landscape
11 Vendor Analysis
12 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global acute ischemic stroke therapeutics market: Athersys Inc., Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Medtronic Plc, NoNO Inc., SanBio Co Ltd., Stryker Corp., Amgen Inc., AstraZeneca Plc, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., Johnson and Johnson, Merck and Co. Inc., Pfizer Inc., Sanofi SA, and Teva Pharmaceutical Industries Ltd.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is TBI, a value-addition in AIS research.`
According to the report, one of the major drivers for this market is the rising prevalence of the disease.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Athersys Inc.
- Bayer AG
- Biogen Inc.
- Boehringer Ingelheim International GmbH
- Medtronic Plc
- NoNO Inc.
- SanBio Co Ltd.
- Stryker Corp.
- Amgen Inc.
- AstraZeneca Plc
- Bristol Myers Squibb Co.
- Daiichi Sankyo Co. Ltd.
- F. Hoffmann La Roche Ltd.
- Johnson and Johnson
- Merck and Co. Inc.
- Pfizer Inc.
- Sanofi SA
- Teva Pharmaceutical Industries Ltd.
